ornithine has been researched along with Movement Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y; Lu, W; Peng, X; Sun, W; Wang, H; Wang, Y; Wu, B; Zhang, P; Zhou, H; Zu, Z | 1 |
| Abdenur, J; Anastasi, A; Ballhausen, D; Billette de Villemeur, T; Buoni, S; Chan, A; Cheillan, D; Dorison, N; Goldenberg, A; Goldstein, J; Hofstede, FC; Jacquemont, ML; Khaikin, Y; Koeberl, DD; Lion-Francois, L; Lund, AM; Mention, K; Mercimek-Andrews, S; Mundy, H; O'Rourke, D; Pitelet, G; Raspall-Chaure, M; Salomons, GS; Sidky, S; Tassini, M; Williams, M | 1 |
| Barshop, BA; El-Gharbawy, AH; Goldstein, JL; Koeberl, DD; Millington, DS; Schlune, A; Schulze, A; Vaisnins, AE; Young, SP | 1 |
| Botto, LD; Ernst, SL; Hedlund, G; Longo, N; Pasquali, M; Viau, KS | 1 |
| Angle, B; Araújo, HC; Barshop, B; Coskun, T; Diogo, L; Geraghty, M; Grolik, C; Haliloglu, G; Konstantopoulou, V; Korenke, GC; Leuzzi, V; Levtova, A; Longo, N; Mackenzie, J; Maranda, B; Marquart, I; Mercimek-Mahmutoglu, S; Mhanni, AA; Mitchell, G; Morris, A; Newlove, T; Nyhan, W; Renaud, D; Scaglia, F; Schlune, A; Schulze, A; Stockler-Ipsiroglu, S; Valayannopoulos, V; van Karnebeek, C; van Spronsen, FJ; Verbruggen, KT; Yuskiv, N | 1 |
| Braissant, O | 1 |
| Nguyen, T; Pitt, JJ; Tzanakos, N | 1 |
| Chan, A; Mercimek-Mahmutoglu, S; Salomons, GS | 1 |
| Clarkson, AN; Connor, BJ; Sun, Y; Van Slooten, AR | 1 |
| Cheillan, D; Dessein, AF; Dobbelaere, D; Fontaine, M; Joncquel-Chevalier Curt, M; Mention-Mulliez, K; Porchet, N; Soto-Ares, G; Vamecq, J; Voicu, PM | 1 |
| Jakobs, C; King, MD; Monavari, A; O'Rourke, DJ; Ryan, S; Salomons, G | 1 |
| De Deyn, PP; Hanefeld, F; Marescau, B; Stöckler, S; Trijbels, JM | 1 |
| Fluharty, AL; Kihara, H; Porter, MT; Valente, M | 1 |
| Bicknell, J; Cavanagh, NP; Howard, F | 1 |
1 review(s) available for ornithine and Movement Disorders
| Article | Year |
|---|---|
Creatine biosynthesis and transport in health and disease.
Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Amino Acid Transport Systems, Basic; AMP-Activated Protein Kinases; Animals; Biological Transport, Active; Brain Diseases, Metabolic, Inborn; Creatine; Developmental Disabilities; Energy Metabolism; Guanidinoacetate N-Methyltransferase; Gyrate Atrophy; Humans; Hyperammonemia; Intellectual Disability; Language Development Disorders; Mental Retardation, X-Linked; Methylation; Mitochondrial Membrane Transport Proteins; Movement Disorders; Mutation; Nerve Tissue Proteins; Ornithine; Plasma Membrane Neurotransmitter Transport Proteins; Prenatal Diagnosis; S-Adenosylmethionine; Speech Disorders; Urea Cycle Disorders, Inborn | 2015 |
13 other study(ies) available for ornithine and Movement Disorders
| Article | Year |
|---|---|
First reported Chinese case of guanidinoacetate methyltransferase deficiency in a 4-year-old child.
Topics: Child, Preschool; Creatine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Guanidinoacetate N-Methyltransferase; Humans; Language Development Disorders; Movement Disorders; Ornithine; Treatment Outcome | 2017 |
Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study.
Topics: Cohort Studies; Creatine; Diet, Protein-Restricted; Female; Guanidinoacetate N-Methyltransferase; Humans; Language Development Disorders; Male; Movement Disorders; Ornithine; Retrospective Studies; Seizures; Treatment Outcome | 2018 |
Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency.
Topics: Case-Control Studies; Child, Preschool; Creatine; Dried Blood Spot Testing; Early Diagnosis; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Infant; Infant, Newborn; Language Development Disorders; Male; Movement Disorders; Ornithine; Treatment Outcome | 2013 |
Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency.
Topics: Creatine; Diet, Protein-Restricted; Female; Genotype; Guanidinoacetate N-Methyltransferase; Humans; Infant; Infant, Newborn; Language Development Disorders; Magnetic Resonance Spectroscopy; Male; Movement Disorders; Mutation; Ornithine; Treatment Outcome | 2013 |
Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring.
Topics: Adolescent; Adult; Arginine; Brain; Child; Child, Preschool; Combined Modality Therapy; Creatine; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Infant; Infant, Newborn; Intellectual Disability; Language Development Disorders; Male; Middle Aged; Movement Disorders; Ornithine; Practice Guidelines as Topic; Sodium Benzoate; Treatment Outcome; Young Adult | 2014 |
GAMT deficiency: 20 years of a treatable inborn error of metabolism.
Topics: Arginine; Creatine; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Intellectual Disability; Language Development Disorders; Male; Movement Disorders; Ornithine; Sodium Benzoate | 2014 |
Newborn screening for guanidinoacetate methyl transferase deficiency.
Topics: Arginine; Creatine; Diet; Female; Glycine; Guanidinoacetate N-Methyltransferase; Humans; Intellectual Disability; Language Development Disorders; Male; Metabolism, Inborn Errors; Movement Disorders; Ornithine; Sodium Benzoate | 2014 |
Case study for the evaluation of current treatment recommendations of guanidinoacetate methyltransferase deficiency: ineffectiveness of sodium benzoate.
Topics: Amino Acids; Child; Creatine; Dietary Supplements; Female; Food Preservatives; Guanidinoacetate N-Methyltransferase; Humans; Language Development Disorders; Magnetic Resonance Spectroscopy; Movement Disorders; Mutation; Ornithine; Protons; Psychological Tests; Sodium Benzoate; Treatment Failure; Treatment Outcome | 2014 |
L-NIO as a novel mechanism for inducing focal cerebral ischemia in the adult rat brain.
Topics: Animals; Blood-Brain Barrier; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Jugular Veins; Male; Movement Disorders; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Ornithine; Rats; Rats, Sprague-Dawley; Time Factors | 2015 |
Guanidinoacetate methyltransferase (GAMT) deficiency: late onset of movement disorder and preserved expressive language.
Topics: Administration, Oral; Adolescent; Age of Onset; Biomarkers; Brain; Creatine; Creatinine; Female; Guanidinoacetate N-Methyltransferase; Humans; Language Development Disorders; Learning Disabilities; Magnetic Resonance Imaging; Movement Disorders; Ornithine; Severity of Illness Index; Treatment Outcome; Twins, Dizygotic | 2009 |
Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis.
Topics: Administration, Oral; Amino Acid Metabolism, Inborn Errors; Creatine; Creatinine; Guanidines; Guanidinoacetate N-Methyltransferase; Humans; Infant; Male; Methyltransferases; Movement Disorders; Ornithine; Time Factors | 1997 |
Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Antipsychotic Agents; Arginine; Chlorpromazine; Cystinuria; Female; Fluphenazine; Humans; Intellectual Disability; Intestinal Absorption; Kidney Tubules; Lysine; Movement Disorders; Ornithine; Pedigree; Renal Aminoacidurias; Thioridazine; Trihexyphenidyl | 1973 |
Cystinuria with mental retardation and paroxysmal dyskinesia in 2 brothers.
Topics: Arginine; Child; Cystinuria; Humans; Intellectual Disability; Lysine; Male; Movement Disorders; Ornithine | 1974 |